Tempest Therapeutics Mean Deviation
| TPST Stock | | | USD 1.93 0.00 0.00% |
The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns. Below is Tempest Therapeutics's current Mean Deviation with peer comparisons and related risk metrics.
Current Mean Deviation Value
Tempest Therapeutics carries a Mean Deviation of 3.98, consistent with moderate price variability. This places Tempest Therapeutics within the typical volatility range for Biotechnology.
Mean Deviation | = | SUM(RET DEV)N |
| = | 3.98 | |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Tempest Therapeutics |
| N | = | Number of calculation points for selected time horizon |
Mean Deviation Peers Comparison
Tempest Therapeutics's Mean Deviation of 3.98 falls above the 3.71 peer average. Values range from 1.41 (Kezar Life Sciences) to 7.16 (Mersana Therapeutics), with wide dispersion across the group. Tempest Therapeutics has exhibited greater price dispersion than the peer average over the measured period.
Mean Deviation Relative To Other Indicators
The chart below plots Mean Deviation against Maximum Drawdown for Tempest Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Mean Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Mean Deviation (
3.98 ) to Maximum Drawdown (
42.25 ) for Tempest Therapeutics yields a
10.61 multiple. This indicates Maximum Drawdown substantially exceeds Mean Deviation for Tempest Therapeutics.
Methodology, Assumptions & Data Sources
Tempest Therapeutics has a current Mean Deviation reading of 3.98. Mean Deviation for Tempest Therapeutics is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Tempest Therapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Values are specific to the selected time horizon and may differ across measurement periods. This indicator does not constitute investment advice.
Other Technical Indicators